{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:17:17Z","timestamp":1782407837824,"version":"3.54.5"},"reference-count":27,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Soci\u00e9t\u00e9 Fran\u00e7aise des Cancers de l\u2019Enfant"},{"name":"the Pediatric Campaign of the Fondation Gustave Roussy \u201cGu\u00e9rir les Cancers des Enfants au XXI si\u00e8cle\u201d."},{"name":"Ecole Normale Sup\u00e9rieure."}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2023,8,21]]},"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:p>Differential diagnosis between <jats:italic>constitutional mismatch repair deficiency (CMMRD)<\/jats:italic> and <jats:italic>neurofibromatosis type 1 (NF1<\/jats:italic>) is crucial as treatment and surveillance differ. We report the case of a girl with a clinical diagnosis of sporadic NF1 who developed a glioblastoma. Immunohistochemistry for MMR proteins identified PMS2 loss in tumour and normal cells and WES showed the tumour had an ultra-hypermutated phenotype, supporting the diagnosis of CMMRD. Germline analyses identified two variants (one pathogenic variant and one classified as variant(s) of unknown significance) in the <jats:italic>PMS2<\/jats:italic> gene and subsequent functional assays on blood lymphocytes confirmed the diagnosis of CMMRD. The large plexiform neurofibroma of the thigh and the freckling were however more compatible with NF1. Indeed, a <jats:italic>NF1<\/jats:italic> PV (variant allele frequencies of 20%, 3% and 9% and in blood, skin and saliva samples, respectively) was identified confirming a mosaicism for NF1. Retrospective analysis of a French cohort identified NF1 mosaicism in blood DNA in 2 out of 22 patients with CMMRD, underlining the existence of early postzygotic PV of <jats:italic>NF1<\/jats:italic> gene in patients with CMMRD whose tumours have been frequently reported to exhibit somatic <jats:italic>NF1<\/jats:italic> mutations. It highlights the potential role of this pathway in the pathogenesis of CMMRD-associated gliomas and argues in favour of testing MEK inhibitors in this context.<\/jats:p>","DOI":"10.1136\/jmg-2023-109235","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T13:20:49Z","timestamp":1695993649000},"page":"158-162","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Neurofibromatosis type 1 mosaicism in patients with constitutional mismatch repair deficiency"],"prefix":"10.1136","volume":"61","clinical-trial-number":[{"clinical-trial-number":"nct04267146","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0050-5407","authenticated-orcid":false,"given":"L\u00e9a","family":"Guerrini-Rousseau","sequence":"first","affiliation":[{"name":"Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Universit\u00e9 Paris-Saclay, Villejuif, France"},{"name":"Molecular Predictors and New Targets in Oncology, Inserm U981 Team \u201cGenomics and Oncogenesis of pediatric Brain Tumors\u201d, Gustave Roussy Cancer Campus, Universit\u00e9 Paris-Saclay, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1881-8762","authenticated-orcid":false,"given":"Eric","family":"Pasmant","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, H\u00f4pital Cochin, DMU BioPhyGen, AP-HP Centre-Universit\u00e9 Paris Cit\u00e9, Paris, France"},{"name":"Inserm U1016-CNRS UMR8104, Institut Cochin, Universit\u00e9 Paris Cit\u00e9, CARPEM, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Muleris","sequence":"additional","affiliation":[{"name":"Department of Genetics, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re. AP-HP. Sorbonne Universit\u00e9, Paris, France"},{"name":"Sorbonne Universit\u00e9, Inserm, Centre de Recherche Saint-Antoine, CRSA, Equipe Instabilit\u00e9 des Microsatellites et Cancer, Equipe labellis\u00e9e par la Ligue Nationale contre le Cancer, F-75012 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Abbou","sequence":"additional","affiliation":[{"name":"Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Universit\u00e9 Paris-Saclay, Villejuif, France"},{"name":"Molecular Predictors and New Targets in Oncology, Inserm U981 Team \u201cGenomics and Oncogenesis of pediatric Brain Tumors\u201d, Gustave Roussy Cancer Campus, Universit\u00e9 Paris-Saclay, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiphaine","family":"Adam-De-Beaumais","sequence":"additional","affiliation":[{"name":"Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Universit\u00e9 Paris-Saclay, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Brugieres","sequence":"additional","affiliation":[{"name":"Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Universit\u00e9 Paris-Saclay, Villejuif, France"},{"name":"Molecular Predictors and New Targets in Oncology, Inserm U981 Team \u201cGenomics and Oncogenesis of pediatric Brain Tumors\u201d, Gustave Roussy Cancer Campus, Universit\u00e9 Paris-Saclay, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Cabaret","sequence":"additional","affiliation":[{"name":"Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9146-9346","authenticated-orcid":false,"given":"Chrystelle","family":"Colas","sequence":"additional","affiliation":[{"name":"Department of Genetics, Institut Curie, PSL Research University, Paris, France"},{"name":"Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.), Equipe Labellis\u00e9e Par la Ligue Nationale Contre le Cancer, Institut Curie, PSL Research University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Cotteret","sequence":"additional","affiliation":[{"name":"Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Decq","sequence":"additional","affiliation":[{"name":"Neurosurgery Department, Beaujon Hospital, Paris Cit\u00e9 University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Dufour","sequence":"additional","affiliation":[{"name":"Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Universit\u00e9 Paris-Saclay, Villejuif, France"},{"name":"Molecular Predictors and New Targets in Oncology, Inserm U981 Team \u201cGenomics and Oncogenesis of pediatric Brain Tumors\u201d, Gustave Roussy Cancer Campus, Universit\u00e9 Paris-Saclay, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erell","family":"Guillerm","sequence":"additional","affiliation":[{"name":"Department of Genetics, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re. AP-HP. Sorbonne Universit\u00e9, Paris, France"},{"name":"Sorbonne Universit\u00e9, Inserm, Centre de Recherche Saint-Antoine, CRSA, Equipe Instabilit\u00e9 des Microsatellites et Cancer, Equipe labellis\u00e9e par la Ligue Nationale contre le Cancer, F-75012 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Rouleau","sequence":"additional","affiliation":[{"name":"Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Varlet","sequence":"additional","affiliation":[{"name":"Service de Neuropathologie, GHU Psychiatrie et Neurosciences, site Sainte-Anne, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa\u00efma","family":"Zili","sequence":"additional","affiliation":[{"name":"Molecular Predictors and New Targets in Oncology, Inserm U981 Team \u201cGenomics and Oncogenesis of pediatric Brain Tumors\u201d, Gustave Roussy Cancer Campus, Universit\u00e9 Paris-Saclay, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Vidaud","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, H\u00f4pital Cochin, DMU BioPhyGen, AP-HP Centre-Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Grill","sequence":"additional","affiliation":[{"name":"Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Universit\u00e9 Paris-Saclay, Villejuif, France"},{"name":"Molecular Predictors and New Targets in Oncology, Inserm U981 Team \u201cGenomics and Oncogenesis of pediatric Brain Tumors\u201d, Gustave Roussy Cancer Campus, Universit\u00e9 Paris-Saclay, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,9,29]]},"reference":[{"key":"2025101714051871000_61.2.158.1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S2352-4642(20)30275-3","article-title":"Predisposition to cancer in children and adolescents","volume":"5","author":"Kratz","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"2025101714051871000_61.2.158.2","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2014-102284"},{"key":"2025101714051871000_61.2.158.3","article-title":"Constitutional mismatch repair deficiency-associated brain tumors: report from the European C4CMMRD consortium","volume":"1","author":"Guerrini-Rousseau","year":"2019","journal-title":"Neurooncol Adv"},{"key":"2025101714051871000_61.2.158.4","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2020-107627"},{"key":"2025101714051871000_61.2.158.5","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106"},{"key":"2025101714051871000_61.2.158.6","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12904"},{"key":"2025101714051871000_61.2.158.7","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2018-105664"},{"key":"2025101714051871000_61.2.158.8","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6058"},{"key":"2025101714051871000_61.2.158.9","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2014.145"},{"key":"2025101714051871000_61.2.158.10","first-page":"i98","article-title":"NF1-like optic pathway gliomas in children: clinical and molecular characterization of this specific presentation","volume":"2","author":"Lob\u00f3n-Iglesias","year":"2020","journal-title":"Neurooncol Adv"},{"key":"2025101714051871000_61.2.158.11","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1053\/j.gastro.2015.06.013","article-title":"Diagnosis of constitutional mismatch repair-deficiency syndrome based on microsatellite instability and lymphocyte tolerance to methylating agents","volume":"149","author":"Bodo","year":"2015","journal-title":"Gastroenterology"},{"key":"2025101714051871000_61.2.158.12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1053\/j.gastro.2022.12.017","article-title":"Constitutional microsatellite instability, genotype, and phenotype correlations in constitutional mismatch repair deficiency","volume":"164","author":"Gallon","year":"2023","journal-title":"Gastroenterology"},{"key":"2025101714051871000_61.2.158.13","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-021-01170-5"},{"key":"2025101714051871000_61.2.158.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.09.048"},{"key":"2025101714051871000_61.2.158.15","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30"},{"key":"2025101714051871000_61.2.158.16","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2013-102238"},{"key":"2025101714051871000_61.2.158.17","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/bjs.11902","article-title":"European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender","volume":"108","author":"Sepp\u00e4l\u00e4","year":"2021","journal-title":"Br J Surg"},{"key":"2025101714051871000_61.2.158.18","first-page":"294","article-title":"Neurofibromatosis and early onset of cancers in hMLH1-deficient children","volume":"59","author":"Wang","year":"1999","journal-title":"Cancer Res"},{"key":"2025101714051871000_61.2.158.19","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20569"},{"key":"2025101714051871000_61.2.158.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrfmmm.2007.08.003"},{"key":"2025101714051871000_61.2.158.21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00439-002-0858-4","article-title":"Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type","volume":"112","author":"Wang","year":"2003","journal-title":"Hum Genet"},{"key":"2025101714051871000_61.2.158.22","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-1050"},{"key":"2025101714051871000_61.2.158.23","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202829"},{"key":"2025101714051871000_61.2.158.24","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209264"},{"key":"2025101714051871000_61.2.158.25","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2164-11-194","article-title":"Evidence of perturbations of cell cycle and DNA repair pathways as a consequence of human and murine NF1-haploinsufficiency","volume":"11","author":"Pemov","year":"2010","journal-title":"BMC Genomics"},{"key":"2025101714051871000_61.2.158.26","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70033-6"},{"key":"2025101714051871000_61.2.158.27","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101818","article-title":"ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1","volume":"56","author":"Carton","year":"2023","journal-title":"EClinicalMedicine"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmg-2023-109235","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T21:05:30Z","timestamp":1760735130000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmg-2023-109235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1,19]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1136\/jmg-2023-109235"],"URL":"https:\/\/doi.org\/10.1136\/jmg-2023-109235","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,29]]}}}